A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.

Clinical trial NCT04573556 · COMPLETED

Trial details

NCT number: NCT04573556
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Sleep Initiation and Maintenance Disorders

Start date: 2020-10-17
Primary completion: 2022-03-17
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.